1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-29
7 classes of this one portfolio · 0 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000028956 | JAGLX | NOT_LISTED | not exchange-listed | — |
| C000077752 | JFNAX | NOT_LISTED | not exchange-listed | — |
| C000077753 | JFNCX | NOT_LISTED | not exchange-listed | — |
| C000077754 | JFNIX | NOT_LISTED | not exchange-listed | — |
| C000198286 | JFNNX | NOT_LISTED | not exchange-listed | — |
| C000077755 | JFNSX | NOT_LISTED | not exchange-listed | — |
| C000083538 | JNGLX | NOT_LISTED | not exchange-listed | — |
N-PORT Item C.4.b
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 90.7% of reported value reaches a classification.
Percentages are of the reported value of positions above ($5.19B), not of the fund’s net assets ($5.20B). The two differ by cash, derivatives filed with no market value, and rounding.
N-PORT Item C.4.a
as filed
104 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co. Eli Lilly & Co. COM NPV | LLY | 532457108 US5324571083 | EC CORP | 499,479 NS | $459.41M | 8.839% | US |
| Johnson & Johnson Johnson & Johnson COM USD1.00 | JNJ | 478160104 US4781601046 | EC CORP | 1,550,240 NS | $378.94M | 7.291% | US |
| AstraZeneca PLC AstraZeneca PLC ORD USD0.25 | AZN | G0593M107 GB0009895292 | EC CORP | 1,221,946 NS | $238.63M GBP | 4.591% | GB |
| AbbVie Inc. AbbVie Inc. COM USD0.01 | ABBV | 00287Y109 US00287Y1091 | EC CORP | 967,983 NS | $210.53M | 4.051% | US |
| UnitedHealth Group Inc. UnitedHealth Group Inc. COM USD0.01 | UNH | 91324P102 US91324P1021 | EC CORP | 601,241 NS | $162.69M | 3.130% | US |
| Novartis AG Novartis AG ADR-REP 1 CHF0.5 (REGD) | NVS | 66987V109 US66987V1098 | OTHER CORP | 971,619 NS | $148.41M | 2.856% | US |
| Thermo Fisher Scientific Inc Thermo Fisher Scientific Inc COM USD1 | TMO | 883556102 US8835561023 | EC CORP | 265,275 NS | $130.39M | 2.509% | US |
| Praxis Precision Medicines Inc Praxis Precision Medicines Inc COM NEW | PRAX | 74006W207 US74006W2070 | EC CORP | 394,970 NS | $127.26M | 2.449% | US |
| Argenx SE Argenx SE SPON ADR EACH REP 1 ORD SHS | ARGX | 04016X101 US04016X1019 | OTHER CORP | 170,830 NS | $124.75M | 2.400% | US |
| Abbott Laboratories Abbott Laboratories COM NPV | ABT | 002824100 US0028241000 | EC CORP | 1,212,497 NS | $124.49M | 2.395% | US |
| Bridgebio Pharma Inc Bridgebio Pharma Inc COM USD0.001 | BBIO | 10806X102 US10806X1028 | EC CORP | 1,551,141 NS | $115.19M | 2.216% | US |
| Roche Holding AG Roche Holding AG CHF0.001 | — | H69293266 CH1499059983 | EP CORP | 290,904 NS | $114.90M CHF | 2.211% | CH |
| Sanofi SA Sanofi SA EUR2 | — | F5548N101 FR0000120578 | EC CORP | 1,116,972 NS | $107.72M EUR | 2.073% | FR |
| Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated COM USD0.… | VRTX | 92532F100 US92532F1003 | EC CORP | 239,922 NS | $107.13M | 2.061% | US |
| Revolution Medicines Inc Revolution Medicines Inc COM | RVMD | 76155X100 US76155X1000 | EC CORP | 1,088,018 NS | $105.81M | 2.036% | US |
| Intuitive Surgical Inc. Intuitive Surgical Inc. COM USD0.001 | ISRG | 46120E602 US46120E6023 | EC CORP | 227,319 NS | $104.79M | 2.016% | US |
| HCA Healthcare Inc HCA Healthcare Inc COM USD0.01 | HCA | 40412C101 US40412C1018 | EC CORP | 206,592 NS | $97.77M | 1.881% | US |
| Boston Scientific Corporation Boston Scientific Corporation COM USD0.01 | BSX | 101137107 US1011371077 | EC CORP | 1,520,117 NS | $95.39M | 1.835% | US |
| Amgen Inc. Amgen Inc. COM USD0.0001 | AMGN | 031162100 US0311621009 | EC CORP | 270,089 NS | $95.03M | 1.828% | US |
| Ascendis Pharma A/S Ascendis Pharma A/S SPON ADR EACH REP 1 ORD S… | — | 04351P101 US04351P1012 | OTHER CORP | 375,183 NS | $85.82M | 1.651% | US |
| Stryker Corporation Stryker Corporation COM USD0.10 | SYK | 863667101 US8636671013 | EC CORP | 260,843 NS | $85.71M | 1.649% | US |
| Danaher Corporation Danaher Corporation COM USD0.01 | DHR | 235851102 US2358511028 | EC CORP | 448,567 NS | $85.05M | 1.636% | US |
| Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc USD0.0001 | MDGL | 558868105 US5588681057 | EC CORP | 149,195 NS | $78.10M | 1.503% | US |
| CVS Health Corp CVS Health Corp COM USD0.01 | CVS | 126650100 US1266501006 | EC CORP | 1,071,894 NS | $76.98M | 1.481% | US |
| Merck & Co., Inc Merck & Co., Inc COM USD0.50 | MRK | 58933Y105 US58933Y1055 | EC CORP | 638,574 NS | $76.81M | 1.478% | US |
| PTC Therapeutics, Inc. PTC Therapeutics, Inc. COM USD0.001 | PTCT | 69366J200 US69366J2006 | EC CORP | 1,024,173 NS | $69.78M | 1.343% | US |
| United Therapeutics Corporation United Therapeutics Corporation COM USD0.01 | UTHR | 91307C102 US91307C1027 | EC CORP | 116,721 NS | $69.21M | 1.332% | US |
| Mckesson Corp. Mckesson Corp. COM USD0.01 | MCK | 58155Q103 US58155Q1031 | EC CORP | 79,818 NS | $69.07M | 1.329% | US |
| Gilead Sciences Inc. Gilead Sciences Inc. COM USD0.001 | GILD | 375558103 US3755581036 | EC CORP | 471,681 NS | $65.74M | 1.265% | US |
| Globus Med Inc Globus Med Inc COM USD0.001 CL 'A' | GMED | 379577208 US3795772082 | EC CORP | 748,604 NS | $64.50M | 1.241% | US |
| Mirum Pharmaceuticals Inc. Mirum Pharmaceuticals Inc. COM USD0.0001 | MIRM | 604749101 US6047491013 | EC CORP | 685,482 NS | $63.32M | 1.218% | US |
| Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. SPON ADS … | TEVA | 881624209 US8816242098 | OTHER CORP | 2,037,481 NS | $61.37M | 1.181% | US |
| Vaxcyte Inc Vaxcyte Inc COM | PCVX | 92243G108 US92243G1085 | EC CORP | 971,737 NS | $56.47M | 1.086% | US |
| Medtronic PLC Medtronic PLC USD0.0001 | MDT | G5960L103 IE00BTN1Y115 | EC CORP | 583,432 NS | $50.55M | 0.973% | US |
| Elevance Health Inc. Elevance Health Inc. COM USD0.01 | ELV | 036752103 US0367521038 | EC CORP | 165,285 NS | $48.39M | 0.931% | US |
| Dyne Therapeutics Inc. Dyne Therapeutics Inc. COM | DYN | 26818M108 US26818M1080 | EC CORP | 2,528,224 NS | $45.84M | 0.882% | US |
| Cencora Inc Cencora Inc COM USD0.01 | COR | 03073E105 US03073E1055 | EC CORP | 139,138 NS | $43.71M | 0.841% | US |
| Travere Therapeutics Inc Travere Therapeutics Inc COM | TVTX | 89422G107 US89422G1076 | EC CORP | 1,432,164 NS | $42.55M | 0.819% | US |
| Lantheus Holdings Inc Lantheus Holdings Inc COM USD0.01 | LNTH | 516544103 US5165441032 | EC CORP | 518,786 NS | $39.35M | 0.757% | US |
| Medline Inc. Medline Inc. COM CL A | MDLN | 58507V107 US58507V1070 | EC CORP | 864,511 NS | $38.47M | 0.740% | US |
| Edwards Lifesciences Corporation Edwards Lifesciences Corporation COM USD1 | EW | 28176E108 US28176E1082 | EC CORP | 465,579 NS | $37.28M | 0.717% | US |
| DexCom Inc DexCom Inc COM USD0.001 | DXCM | 252131107 US2521311074 | EC CORP | 561,491 NS | $35.26M | 0.678% | US |
| Soleno Therapeutics Inc Soleno Therapeutics Inc COM | — | 834203309 US8342033094 | EC CORP | 987,780 NS | $33.07M | 0.636% | US |
| Apogee Therapeutics Inc. Apogee Therapeutics Inc. COM | APGE | 03770N101 US03770N1019 | EC CORP | 379,608 NS | $31.95M | 0.615% | US |
| UCB SA UCB SA NPV | — | B93562120 BE0003739530 | EC CORP | 104,561 NS | $31.49M EUR | 0.606% | BE |
| Becton, Dickinson and Company Becton, Dickinson and Company COM USD1.00 | BDX | 075887109 US0758871091 | EC CORP | 181,577 NS | $28.55M | 0.549% | US |
| Glaukos Corp. Glaukos Corp. COM USD0.001 | GKOS | 377322102 US3773221029 | EC CORP | 264,704 NS | $28.50M | 0.548% | US |
| Structure Therapeutics Inc Structure Therapeutics Inc SPONSORED ADS | GPCR | 86366E106 US86366E1064 | OTHER CORP | 569,589 NS | $27.45M | 0.528% | US |
| IDEAYA Biosciences Inc. IDEAYA Biosciences Inc. COM USD0.0001 | IDYA | 45166A102 US45166A1025 | EC CORP | 738,748 NS | $24.62M | 0.474% | US |
| Penumbra Inc. Penumbra Inc. COM USD0.001 | PEN | 70975L107 US70975L1070 | EC CORP | 73,736 NS | $24.21M | 0.466% | US |